TTRXTurn Therapeutics Inc.
$6.82
$6.82
$2.7152 weeks$15.28
TTRX as reported
- Net income
- −$8.4M
Net income · trailing twelve months to Q2 2026
- EPS
- −$0.29
EPS · trailing twelve months to Q2 2026
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Net income | −$8.4M | n/a | Q2 2026 |
| EPS | −$0.29 | n/a | Q2 2026 |
| ROE | −528% | n/a | Q2 2026 |
| ROA | −46% | n/a | Q2 2026 |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Turn Therapeutics Inc. (TTRX) · Net incomeNet incomeTurn Therapeutics Inc. (TTRX)
Biotechnology
The closest names by size in the same industry